Background: In addition to determining the cumulative incidence and risk factors for early seizures (ES), late seizures (LS) and post stroke epilepsy (PSE), we aimed at checking if ES represented a risk factor for epilepsy and if early treatment after ES prevented the occurrence of subsequent seizures. Methods: This study was part of a 2-year prospective community-based registry of all cerebrovascular events in the district of Udine (153,312 inhabitants), North-Eastern Italy, between April 1, 2007 and March 31, 2009. People with transient ischemic attacks (TIAs) were excluded from this study. Results: In all, 782 cases of stroke (79.28% ischemic, 14.83% hemorrhagic, 3.20% subarachnoid hemorrhage and 2.69% undetermined) were identified. The incidence of ES, LS and PSE was 5.10, 3.14 and 2.22%, respectively. Intracerebral hemorrhage, subarachnoid hemorrhage, stroke of undetermined origin and hyponatremia, represented risk factors for ES (p < 0.05). Among ischemic strokes, ES risk factors were hyponatremia (p = 0.024) and hemorrhagic transformation (p = 0.046). LS risk factors were younger age (p = 0.004) and cortical location of stroke (p = 0.004). Within ischemic strokes, LS risk factors were younger age (p = 0.020) and cortical location (p < 0.0001). Within intracerebral hemorrhages, the only risk factor for LS was the presence of a previous ES (p = 0.017). PSE risk factors were the same as for LS. Conclusions: All acute conditions related to the occurrence of stroke are implicated in the pathogenesis of ES, which becomes a risk factor for LS only in the setting of intracerebral hemorrhages. Therefore, early antiepileptic treatment is needed only in this situation.

1.
Loiseau J, Loiseau P, Duché B, Guyot M, Dartigues JF, Aublet B: A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann Neurol 1990;27:232-237.
2.
Forsgren L, Bucht G, Eriksson S, Bergmark L: Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996;37:224-229.
3.
Procaccianti G, Zaniboni A, Rondelli F, Crisci M, Sacquegna T: Seizures in acute stroke: incidence, risk factors and prognosis. Neuroepidemiology 2012;39:45-50.
4.
Jungehulsing GJ, Heuschmann PU, Holtkamp M, Schwab S, Kolominsky-Rabas PL: Incidence and predictors of post-stroke epilepsy. Acta Neurol Scand 2013;127:427-430.
5.
Lossius MI, Rønning OM, Mowinckel P, Gjerstad L: Incidence and predictors for post-stroke epilepsy. A prospective controlled trial. The Akershus stroke study. Eur J Neurol 2002;9:365-368.
6.
Kammersgaard LP, Olsen TS: Poststroke epilepsy in the Copenhagen stroke study: incidence and predictors. J Stroke Cerebrovasc Dis 2005;14:210-214.
7.
Labovitz DL, Hauser WA, Sacco RL: Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001;57:200-206.
8.
Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C: Epileptic seizures after a first stroke: the Oxfordshire community stroke project. BMJ 1997;315:1582-1587.
9.
Shinton RA, Gill JS, Melnick SC, Gupta AK, Beevers DG: The frequency, characteristics and prognosis of epileptic seizures at the onset of stroke. J Neurol Neurosurg Psychiatry 1998;51:273-276.
10.
So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP: Population-based study of seizure disorders after cerebral infarction. Neurology 1996;46:350-355.
11.
Menon B, Shorvon SD: Ischaemic stroke in adults and epilepsy. Epilepsy Res 2009;87:1-11.
12.
Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, Lebrun L, Pirisi A, Norris JW: Seizures after stroke: a prospective multicenter study. Arch Neurol 2000;57:1617-1622.
13.
Reith J, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS: Seizures in acute stroke: predictors and prognostic significance. The Copenhagen stroke study. Stroke 1997;28:1585-1589.
14.
Silverman IE, Restrepo L, Mathews GC: Poststroke seizures. Arch Neurol 2002;59:195-201.
15.
Carrera E, Michel P, Despland PA, Maeder-Ingvar M, Ruffieux C, Debatisse D, Ghika J, Devuyst G, Bogousslavsky J: Continuous assessment of electrical epileptic activity in acute stroke. Neurology 2006;67:99-104.
16.
Lancman ME, Golimstok A, Norscini J, Granillo R: Risk factors for developing seizures after a stroke. Epilepsia 1993;34:141-143.
17.
Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, Tomson T, Hauser WA: Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010;51:671-675.
18.
Pezzini A, Grassi M, Del Zotto E, Giossi A, Volonghi I, Costa P, Poli L, Morotti A, Gamba M, Ritelli M, Colombi M, Padovani A: Complications of acute stroke and the occurrence of early seizures. Cerebrovasc Dis 2013;35:444-450.
19.
Jungehulsing GJ, Heuschmann PU, Holtkamp M, Schwab S, Kolominsky-Rabas PL: Incidence and predictors of post-stroke epilepsy. Acta Neurol Scand 2013;127:427-430.
20.
Gupta SR, Naheedy MH, Elias D, Rubino FA: Postinfarction seizures. A clinical study. Stroke 1988;19:1477-1481.
21.
Janes F, Gigli GL, D'Anna L, Cancelli I, Perelli A, Canal G, Russo V, Zanchettin B, Valente M: Stroke incidence and 30-day and six-month case fatality rates in Udine, Italy: a population-based prospective study. Int J Stroke 2013;8(suppl A100):100-105.
22.
Cancelli I, Janes F, Gigli GL, Perelli A, Zanchettin B, Canal G, D'Anna L, Russo V, Barbone F, Valente M: Incidence of transient ischemic attack and early stroke risk: validation of the ABCD2 score in an Italian population-based study. Stroke 2011;42:2751-2757.
23.
Feigin V, Hoorn SV: How to study stroke incidence. Lancet 2004;363:1920-1921.
24.
Feigin VL, Carter K: Editorial comment - stroke incidence studies one step closer to the elusive gold standard? Stroke 2004;35:2045-2047.
25.
Coull AJ, Silver LE, Bull LM, Giles MF, Rothwell PM; Oxford Vascular (OXVASC) Study: direct assessment of completeness of ascertainment in a stroke incidence study. Stroke 2004;35:2041-2045.
26.
Hatano S: Experience from a multicentre stroke register: a preliminary report. Bull WHO 1976;54:541-553.
27.
WHO STEPS Stroke Manual: The WHO STEPwise Approach to Stroke Surveillance. Geneva, WHO, 2005, vol 87, pp 1-11.
28.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
29.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshé SL, Nordli D, Plouin P, Scheffer IE: Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on classification and terminology, 2005-2009. Epilepsia 2010;51:676-685.
30.
Guidelines for epidemiologic studies on epilepsy. Commission on epidemiology and prognosis, international league against epilepsy. Epilepsia 1993;34:592-596.
31.
Giroud M, Gras P, Fayolle H, André N, Soichot P, Dumas R: Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 1994;35:959-964.
32.
Benbir G, Ince B, Bozluolcay M: The epidemiology of post-stroke epilepsy according to stroke subtypes. Acta Neurol Scand 2006;114:8-12.
33.
Lamy C, Domigo V, Semah F, Arquizan C, Trystram D, Coste J, Mas JL; Patent Foramen Ovale and Atrial Septal Aneurysm Study Group: Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003;60:400-404.
34.
Lossius MI, Ronning OM, Slapo GD, Mowinckel P, Gjerstad L: Poststroke epilepsy: occurrence and predictors - a long-term prospective controlled study (Akershus stroke study). Epilepsia 2005;46:1246-1251.
35.
Huang CW, Saposnik G, Fang J, Steven DA, Burneo JG: Influence of seizures on stroke outcomes: a large multicenter study. Neurology 2014;82:768-776.
36.
Conrad J, Pawlowski M, Dogan M, Kovac S, Ritter MA, Evers S: Seizures after cerebrovascular events: risk factors and clinical features. Seizure 2013;22:275-282.
37.
Heuts-van Raak L, Lodder J, Kessels F: Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure 1996;5:185-194.
38.
Kilpatrick CJ, Davis SM, Hopper JL, Rossiter SC: Early seizures after acute stroke. Risk of late seizures. Arch Neurol 1992;49:509-511.
39.
Williams AJ, Tortella FC: Topographic EEG mapping following experimental stroke in rats and treatment with the neuroprotective sodium channel blocker RS 100642. Soc Neurosci 2000;26:abstr 502.
40.
Williams AJ, Lu XM, Slusher B, Tortella FC: Electroencephalogram analysis and neuroprotective profile of the N-acetylated-alpha-linked acidic dipeptidase inhibitor, GPI5232, in normal and brain-injured rats. J Pharmacol Exp Ther 2001;299:48-57.
41.
D'Anna L, Gigli GL, Gregoraci G, Canal G, Giopato F, Janes F, Perelli A, Russo V, Zanchettin B, Valente M: Identification of stroke etiology may contribute to improve the outcome in dedicated units. J Stroke Cerebrovasc Dis 2015;24:802-810.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.